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MSP58, PTENy identiﬁed on the basis of its speciﬁc activation in avian ﬁbroblasts transformed
by the v-jun oncogene of avian sarcoma virus 17 (ASV17). Overexpression of TOJ3 induces cellular
transformation of embryonic avian ﬁbroblasts, revealing an intrinsic oncogenic potential. Transforming
activity has also been demonstrated for MSP58, the human homolog of TOJ3, and oncogenic cell
transformation by MSP58 is speciﬁcally inhibited by the tumor suppressor PTEN. To investigate the
mechanism of aberrant TOJ3 gene activation in jun-transformed ﬁbroblasts, the entire quail TOJ3 gene
including 13 exons and the 5′ regulatory region was isolated. Functional analyses of the promoter by
transcriptional transactivation assays revealed that the speciﬁc induction of TOJ3 is mediated by a cluster of
three noncanonical AP-1 binding motifs (5′-CAGCTCA-3′ or 5′-CACCTCA-3′) which share the 3′ half-site with
the consensus motif (5′-TGAC/GTCA-3′). Electrophoretic mobility shift assays and chromatin immunopreci-
pitation analyses showed that Jun binds to these motifs with an afﬁnity similar to that observed for binding
to an AP-1 consensus site. Noncanonical binding sites are also present in the chicken and human TOJ3/MSP58
promoter regions. These results conﬁrm and extend the previous observation that TOJ3 represents an
immediate effector gene of Jun and may point to an essential role of TOJ3/MSP58 in carcinogenesis involving
aberrant AP-1 expression.
© 2008 Elsevier Inc. All rights reserved.Introduction
The dimeric AP-1 (activator protein-1) transcription factor complex
containing c-Jun, c-Fos, or related proteins regulates the expression of
genes relevant for cell proliferation and differentiation (Rauscher et al.,
1988; Vogt, 2001, 2002; Eferl andWagner, 2003). AP-1 bindswith high
afﬁnity to the consensus sequence 5′-TGAC/GTCA-3′, or variants there-
of, in the promoters of speciﬁc target genes (van Dam and Castellazzi,
2001; Eferl and Wagner, 2003). Numerous genes have been identiﬁed
that are differentially expressed in cells transformed by the v-jun
oncogene (Maki et al., 1987) of avian sarcoma virus 17 (ASV17),
including genes which are directly regulated by AP-1 (van Dam and
Castellazzi, 2001; Vogt, 2001; Hartl et al., 2003; Black et al., 2004;
Iacovoni et al., 2004). However, only a few AP-1 targets have been
identiﬁed that display intrinsic oncogenic potential, including TOJ3,
originally discovered on the basis of its immediate and speciﬁc
activation in avian ﬁbroblasts transformed by the ASV17 v-jun
oncogene (Bader et al., 2001). The 530-amino acid protein product
(TOJ3) of the TOJ3 gene is the avian homolog of microspherule, klaus.bister@uibk.ac.at
l rights reserved.protein 1 (MSP58/MCRS1), containing a bipartite nuclear localization
motif and a phosphopeptide binding module (forkhead-associated
domain, FHA) (Bader et al., 2001). Human MSP58 is localized in the
nucleus and presumably acts in concert with distinct protein
binding partners as a cell cycle-dependent transcriptional cofactor
important for cell proliferation (Lin and Shih, 2002; Shimono et al.,
2005; Du et al., 2006). Furthermore, MSP58 interacts with transfor-
mation associated proteins (Bruni and Roizman,1998; Ren et al., 1998)
or tumor suppressors (Okumura et al., 2005), including PTEN that
frequently shows a loss of function in various human cancer types
(Simpson and Parsons, 2001). Direct interaction with PTEN abrogates
the oncogenic function of MSP58 (Okumura et al., 2005), suggesting
that the TOJ3/MSP58 genes may play an important role in human
cancer.
Results and discussion
To explore the mechanism of aberrant transcriptional TOJ3
activation, we have isolated the entire quail TOJ3 gene. Using a 5′-
fragment of TOJ3 cDNA as a probe, a genomic quail library was
screened leading to the isolation of two overlapping DNA fragments of
1141 and 3926 bp, respectively. The assembled 4538-bp nucleotide
sequence encompasses the promoter region and 13 exons of the TOJ3
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scribed region, the previouslymapped transcription start site (Bader et
al., 2001), and a potential TATA box at nucleotide positions −28 to −23.
No consensus AP-1 binding site (5′-TGAC/GTCA-3′) was found, but 19
potential nonconsensus AP-1 binding motifs with the sequence 5′-
CAGCTCA-3′ (18×) or 5′-CACCTCA-3′ (1×). In both motifs, the 3′-half
(CTCA) of the consensus site is retained (Fig.1B). Three of the 19motifs
are located in close proximity to the transcription start site (−100 to
−94, −81 to −75, −62 to −56), referred to as the distal (D), central (C), or
proximal (P) site. Comparison of the quail TOJ3 promoter with the
corresponding region of the chicken TOJ3 gene (from contig
NW_001471752 of the chicken genome sequence) showed a high
degree of conservation from nucleotide positions −69 to +8 including
the proximal 5′-CACCTCA-3′ motif (Fig. 1C). Furthermore, six 5′-Fig. 1. Structure of the quail TOJ3 gene. (A) The schematic diagram indicates the 13 exon
polyadenylation signal, restriction enzyme cleavage sites, and the structures of mRNA and
containing 19 nonconsensus AP-1 binding motifs (5′-CAC/GCTCA-3′), a TATA box (5′-AATAAA
and the translational start site. (C) Diagram of the chicken and quail TOJ3 promoters showin
(arrows). BLAST analysis of quail TOJ3 promoter sequences was used to identify the c
immunoprecipitation (ChIP) analyses are indicated. The nucleotide and deduced amino acid
EU116502).CAGCTCA-3′ motifs are present in the chicken TOJ3 promoter. MSP58,
the human TOJ3 homolog, is located on chromosome 12 and contained
within contig NT_029419.11 of the human genome sequence. Notably,
the overall MSP58 gene topology is very similar to that of TOJ3,
encompassing 15 exons and displaying a cluster of 15 variant AP-1
binding sites in the 5′ upstream region (not shown), some of which
have been described as functional sites in other AP-1 targets.
For functional promoter analysis, DNA fragments encompassing
the quail or chicken TOJ3 promoter were inserted into chloramphe-
nicol acetyltransferase (CAT) reporter plasmids yielding the constructs
pCAT-qTOJ3 and pCAT-cTOJ3. Transient transfection of the pCAT-
qTOJ3 or pCAT-cTOJ3 plasmids into ASV17-transformed quail embryo
ﬁbroblasts (QEF) revealed that both avian TOJ3 promoters are strongly
activated, even stronger than the promoter of the direct AP-1 targets with the coding region shown in black, the transcriptional initiation site (arrow), a
protein product. (B) Nucleotide sequence of a 1141-bp TOJ3 promoter/exon1 fragment,
-3′), the previously mapped transcriptional start site at position +1 (Bader et al., 2001),
g the positions of potential AP-1 binding sites (BS) and of the transcriptional start sites
orresponding region in the chicken genome. The regions ampliﬁed for chromatin
sequences reported here have been deposited in the GenBank database (accession no.
373A.I. Karagiannidis et al. / Virology 378 (2008) 371–376BKJ (Hartl and Bister, 1995, 1998) containing two consensus AP-1
binding sites (Fig. 2A). No promoter activities were observed in v-myc-
transformed cells or in normal QEF. To test directly if AP-1 components
are necessary for transcriptional activation, the promoter constructFig. 2. Speciﬁc activation of the TOJ3 promoter mediated by nonconsensus AP-1 binding sit
containing the quail or chicken TOJ3 promoter regions, respectively, were transfected into
retroviruses encoding Gag-Jun (Maki et al., 1987) or Gag-Myc (Bister et al., 1977) hybrid prot
and from the pCAT-qBKJ promoter construct of the direct AP-1 target gene BKJ (Hartl and Bist
as controls. Aliquots of total cell extracts containing equal amounts of protein (10 μg) were
autoradiography. Positions of [14C]chloramphenicol (CAM), of acetylated products (1-acety
indicated. (B) 2.5 μg aliquots of pCAT-qTOJ3 DNA were transfected into QEF together with
encoding v-Jun, c-Jun, JunD, c-Fos, Fra-2, or v-Myc proteins. Cell extracts containing equal am
promoter activity. Equal amounts of the CAT gene constructs (2.5 μg) were transfected into
performed using cell extracts containing equal amounts of protein (2.5 μg).pCAT-qTOJ3 was cotransfected with eucaryotic expression vectors
specifying v-Jun, c-Jun, c-Fos, the Jun- and Fos-related proteins JunD
and Fra-2, or v-Myc into normal QEF (Fig. 2B). The analysis revealed
that high level expression of v-Jun led to strong activation of the TOJ3es. (A) 5.0 μg aliquots of DNA from the CAT gene constructs pCAT-qTOJ3 or pCAT-cTOJ3
normal quail embryo ﬁbroblasts (QEF) or into QEF transformed by the ASV17 or MC29
eins, respectively. Equal amounts of DNA from the empty pCAT-Basic vector (Promega)
er, 1995, 1998) containing two consensus AP-1 binding sites (5′-TGACTCA-3′) were used
used for the acetylation reactions. Reaction products were resolved and visualized by
l-, 3-acetyl-, 1,3-diacetyl-[14C]chloramphenicol), and extent (%) of total acetylation are
equal amounts of DNA from the pRc/RSV empty vector, or from expression constructs
ounts of protein (10 μg) were tested. (C) Mutational analysis of quail and chicken TOJ3
QEF together with 2.5 μg aliquots of the pRc-v-Jun expression vector. CAT analysis was
374 A.I. Karagiannidis et al. / Virology 378 (2008) 371–376promoter. Moderate activation was also observed upon ectopic
expression of the cellular counterpart c-Jun, which is in agreement
with a weak increase of TOJ3 mRNA levels in c-jun-transformed cells
(not shown). No activation was seen with overexpressed c-Fos, JunD,
Fra-2, or v-Myc.
In order to localize the TOJ3 promoter region essential for the
speciﬁc activation by v-Jun, several pCAT-qTOJ3 and pCAT-cTOJ3
derivatives were generated with progressive deletions, including
mutants of a minimal quail (pCAT-qTOJ3-min) or chicken TOJ3
promoter (pCAT-cTOJ3-P) with deletions of the distal, central, or
proximal AP-1 binding sites. These constructs were cotransfected into
QEF together with an expression vector encoding the v-Jun protein
(Fig. 2C). The analysis revealed that the 5′-deletion mutant pCAT-
qTOJ3-min containing 131 bp with three potential AP-1 binding sites
retained full promoter activity, whereas the construct pCAT-qTOJ3-
ΔREPΔDCP lacking these sites has no activity. The integrity of the
minimal promoter fragment is essential, since successive deletions
yielding the constructs pCAT-qTOJ3-CP and pCAT-qTOJ3-P led to
diminished CAT activity (Fig. 2C). To directly investigate if the three
heptameric binding motifs are essential for transcriptional activation,
mutants from pCAT-qTOJ3-min were generated in which the 7-bp
sequences representing the distal (pCAT-qTOJ3-minΔD), the central
(pCAT-qTOJ3-minΔC), or the proximal (pCAT-qTOJ3-minΔP) site were
deleted individually. Inactivation of any site led to a reduction in
transcriptional activity, whereas speciﬁc deletion of all three binding
motifs (pCAT-qTOJ3-minΔDCP) led to complete abrogation of CAT
activity, suggesting that these sites act synergistically. Consistently, a
deletion mutant of the chicken TOJ3 promoter construct containing
only the proximal AP-1 binding site (pCAT-cTOJ3-P) gave rise to
reduced CAT activity, whereas deletion of this site (pCAT-cTOJ3-PΔP)
led to complete promoter inactivation (Fig. 2C).
To directly demonstrate speciﬁc interaction of Jun with the
noncanonical AP-1 binding sites in the TOJ3 promoter, double-
stranded 23-mer oligodeoxynucleotides containing the 5′-CAGCTCA-
3′ or 5′-CACCTCA-3′ motifs were used for electrophoretic mobility
shift assays (EMSA) (Fig. 3A). A homodimer of recombinant Jun protein
bound to this DNA probe with equal speciﬁcity compared to a control
probe containing the consensus AP-1 site from the promoter of theFig. 3. Speciﬁc binding of recombinant Jun to the TOJ3 promoter. (A) 32P-labeled 23-bp dou
binding site (5′-TCCAGGCCTGACTCAGCAGCCTC-3′) from the quail BKJ promoter (Hartl and
TATAGGGACACCTCACCCCTATA-3′) nonconsensus AP-1 binding motif from the quail TOJ3 pr
assays (EMSA). The probes were incubated with no protein, or with solubilized and renature
Myc p16 (Kerkhoff et al., 1991) or chicken Jun recombinant protein CV (Hartl et al., 2001), in
mutated (BS-mut; 5′-TATAGGAAAGACCCAGCCCTATA-3′) AP-1 binding site oligodeoxyn
(B) Dissociation constants of Jun–DNA complexes were determined using the same DNA p
probes was competed by increasing amounts of unlabeled AP1-BS oligodeoxynucleotides as
and Bister, 1998).direct Jun target BKJ (Hartl and Bister, 1995, 1998). The speciﬁcity of
the protein-DNA interactions was demonstrated by adding the
unlabeled DNA probe as a competitor (BS), or an oligodeoxynucleotide
with a mutated AP-1 binding site (BS-mut) as a control (Fig. 3A).
Competition with unlabeled DNA probe was also used to estimate the
dissociation constant (KD) of the protein-DNA complex as described
previously (Papoulas et al., 1992; Hartl and Bister, 1998) (Fig. 3B). For
binding of Jun to the consensus AP-1 site in the BKJ promoter (Hartl
and Bister, 1998), a KD of 0.8×10−7 M was determined, whereas for
binding to the 5′-CAGCTCA-3′ or the 5′-CACCTCA-3′ element in the
TOJ3 promoter KD values of 2.0×10−7 M or 1.1×10−7 Mweremeasured,
respectively.
To test if these sites were also recognized by AP-1 protein
complexes formed in vivo, EMSA and supershift EMSA were
performed using nuclear extracts prepared from ASV17-transformed
QEF or from normal QEF (Fig. 4A). Speciﬁc binding activity was
detected in nuclear extracts containing v-Jun. The speciﬁcity of
binding was demonstrated by unlabeled probe competition and by
complete (α-Jun) or partial (a-Fos) antibody inhibition. As reported
previously, Jun or Fos antibodies inhibit DNA binding in EMSA
analyses, rather than inducing supershifts (Hartl et al., 2001; 2006).
Application of normal rabbit serum (NRS) did not interfere with DNA
binding (Fig. 4A). The extracts both from normal or transformed QEF
also contained proteins that formed uniform complexes with the
probe. However, formation of these bands was not inhibited by Jun- or
Fos-speciﬁc antisera, in contrast to the additional larger complexes
observed only in extracts from v-jun-transformed cells (Fig. 4A).
Further independent evidence for direct binding of Jun complexes to
the TOJ3 promoter was obtained by chromatin immunoprecipitation
(ChIP) analysis (Fig. 4B), using cross-linked chromatin fromQEF/ASV17
or CEF/ASV17 cells, Fos-, Jun-, or Gag-speciﬁc antibodies, and PCR
primer pairs for ampliﬁcation of a 381-bp or a 177-bp DNA segment
encompassing the functional AP-1 binding sites of the quail or chicken
TOJ3 promoter, respectively (cf. Fig. 1C). PCR analysis speciﬁcally
produced a 381-bp or a 177-bp DNA fragment when Jun- or Gag-
speciﬁc antibodies were used for the ChIP analysis, corroborating the
ﬁnding that the Gag-Jun hybrid protein of ASV17 binds speciﬁcally to
the AP-1 motifs present in the quail and chicken TOJ3 promoter. Lowble-stranded oligodeoxynucleotides (AP-1 BS; 10 nM) containing the consensus AP-1
Bister, 1998), or the central (5′-TATAGGAACAGCTCAGCCCTATA-3′) or the proximal (5′-
omoter (cf. Fig. 1) were used as probes (1.5×105 cpm) for electrophoretic mobility shift
d proteins (0.8 μg) fromwashed inclusion bodies containing v-Myc recombinant protein
the absence or presence of a 125-fold excess (1.25 mM) of unlabeled wild type (BS) or
ucleotide. Autoradiography was performed for 6 h using an intensifying screen.
robes (5 nM) as in (A) and Jun recombinant protein CJ (0.6 μg). Binding to the labeled
indicated, and the KD values were calculated as described (Papoulas et al., 1992; Hartl
Fig. 4. Speciﬁc binding of Jun from ASV17-transformed cells to the TOJ3 promoter.
(A) EMSA analysis using the same 32P-labeled TOJ3-speciﬁc DNA probes (5 nM;
4.0×104 cpm) as in Fig. 3 and equal amounts of nuclear proteins (14 μg) from normal
QEF or from ASV17-transformed QEF. Incubations were also carried out in the presence
of 1 μl aliquots of normal rabbit serum (NRS), or of speciﬁc antisera (α) directed against
Jun or Fos proteins, or in the presence of unlabeled AP-1 BS competitor DNA (500 nM).
Autoradiography was performed for 48 h using an intensifying screen. (B) Chromatin-
immunoprecipitation (ChIP) analysis of sheared extracts derived from formaldehyde-
treated ASV17-transformed QEF or CEF, or normal QEF or CEF. Immunoprecipitations
were carried out using Jun-, Fos- or Gag-speciﬁc antibodies followed by PCR
ampliﬁcation of a 381-bp or a 177-bp fragment from the quail or chicken TOJ3
promoter regions, respectively, containing the essential AP-1 binding sites (cf. Fig. 1B).
Control reactions included samples treated with no antibody or with NRS. PCR products
were analyzed by agarose (1.4%, wt/vol) gel electrophoresis, and visualized by ethidium
bromide staining.
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was used, in agreement with the partial inhibition of complex
formation in the EMSA analysis by Fos serum, indicating that the
ASV17 Gag-Jun protein at least partially recruits endogenous Fos for
dimerization. As a control, ChIP was performed using chromatin from
normal QEF or CEF yielding no speciﬁc PCR products, in agreement
with the lack of Jun- or Fos-related complex formation in the EMSA
analysis using normal cell extracts (cf. Fig. 4A).
These results show that the TOJ3 gene is a direct transcriptional
target of Jun in jun-transformed cells. Notably, high-afﬁnity interac-
tion with the TOJ3 promoter occurs via nonconsensus AP-1 binding
motifs. In view of its intrinsic oncogenic potential (Bader et al., 2001),
TOJ3 belongs to the important group of AP-1 target genes which may
contribute directly to malignant cell transformation. To reveal thespeciﬁc role of the TOJ3 protein in carcinogenesis, elucidation of its
biochemical function will be required.
Materials and methods
Cells and retroviruses
Preparation, culture, and transformation of chicken or quail
embryo ﬁbroblasts (CEF, QEF) derived from fertile Japanese quail
(Coturnix japonica) or chicken (Gallus gallus) eggs have been described
(Hartl and Bister, 1998; Bader et al., 2001; Hartl et al., 2001, 2006).
Infection of QEF with the avian retroviruses ASV17 (Maki et al., 1987)
or MC29 (Bister et al., 1977) encoding Gag-Jun or Gag-Myc hybrid
proteins, respectively, and of CEF with ASV17 was performed as
described previously (Hartl and Bister, 1998; Hartl et al., 2001).
DNA cloning and nucleic acid analyses
DNA labeling, plaque hybridization, and subcloning were per-
formed as described (Hartl and Bister, 1998; Bader et al., 2001; Hartl
et al., 2001, 2006). For the isolation and sequencing of overlapping
DNA fragments encompassing the TOJ3 gene, a quail genomic library
was screened as described (Hartl and Bister, 1998) using a 165-bp
NcoI fragment derived from the 5′-region of TOJ3 cDNA as a probe
(Bader et al., 2001). Enzymatic DNA sequencing from subcloned DNA
fragments was performed as described using 35S-α-dATP (Hartl and
Bister, 1998) or ﬂuorescence-labeld dideoxynucleotides (Applied
Biosystems) in cycle sequencing reactions. Reaction products were
resolved either by denaturing polyacrylamide gelelectrophoresis as
described (Hartl and Bister, 1998) or by using a 16-capillary
sequenator (Applied Biosystems), respectively. Bioinformatic ana-
lyses of nucleotide sequences and sequence interpretation were
performed as described (Hartl and Bister, 1998; Bader et al., 2001;
Hartl et al., 2001, 2006). BLAST analyses of quail TOJ3 promoter and
of cDNA sequences were used to identify the corresponding region in
the chicken genome (accession no. NW_001471752). The nucleotide
sequence of the quail TOJ3 gene has been deposited in the GenBank
database (accession no. EU116502).
Transactivation analysis
The construct pCAT-qBKJ containing the quail BKJ promoter has
been described (Hartl and Bister, 1998; Hartl et al., 2001). For
construction of the chloramphenicol acetyltransferase (CAT) reporter
plasmid pCAT-qTOJ3, pCAT-Basic was cut with XbaI, ﬁlled in with
Klenow polymerase, and then cut with PstI. A 1107-bp quail TOJ3
promoter fragment generated by cleavage with BspHI at the 3′ end,
treatment with mung bean nuclease, and cleavage with PstI at the 5′
end, was then inserted. To construct pCAT-cTOJ3, a chicken genomic
DNA fragment corresponding to the quail TOJ3 promoter (nt positions
1055–1511 of sequence contig NW_001471752) was ampliﬁed by PCR
and inserted into the pCAT-Basic vector using the polylinker PstI/XbaI
restriction enzyme sites. Sequencing of the promoter insert revealed
four nucleotide substitutions and a single nucleotide deletion
compared to the NW_001471752 database sequence (A/G, T/A, A/G,
C/T, ΔC at positions 1116, 1180, 1365, 1393, 1401, respectively). pCAT-
qTOJ3-min contains nucleotides −107 to +22 of the quail TOJ3
promoter and was generated by PCR using pCAT-qTOJ3 as a template
and primers containing HindIII and XbaI restriction enzyme sites for
ligation into pCAT-Basic. pCAT-qTOJ3-CP and pCAT-qTOJ3-P encom-
pass nucleotides −89 to +22 or −75 to +22 and were generated by PCR
using pCAT-qTOJ3-min or pCAT-qTOJ3-CP as a template, and speciﬁc
primers containing PstI and XbaI restriction enzyme sites. To construct
pCAT-qTOJ3ΔREPΔDCP, PCR mutagenesis using overlapping primers
and pCAT-qTOJ3 as a template was performed leading to deletion of
nucleotides −383 to −49. In pCAT-qTOJ3-minΔD, pCAT-qTOJ3-minΔC,
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(C), proximal (P), or all (DCP) heptamer motifs representing AP-1
binding sites (black boxes) were deleted using PCR mutagenesis.
pCAT-cTOJ3-P was generated by deleting a PstI/PvuII fragment
containing nucleotides 1055–1307 of sequence NW_001471752 from
pCAT-cTOJ3. Deletion of the proximal (P) AP-1 binding site by PCR
mutagenesis using pCAT-cTOJ3-P as a template yielded a cTOJ3-PΔP
fragment which was inserted into a HindIII/XbaI-cut pCAT-Basic
vector. The eucaryotic expression vectors pRc-c-Jun, pRc-JunD, pRc-v-
Jun, pRc-c-Fos, pRc-Fra-2, pRc-v-Myc expressing the relevant proteins
at approximately equal amounts have been described (Hartl et al.,
2001, 2006). DNA transfer into cells by the calcium phosphate method,
CATanalysis and quantiﬁcation of radioactive signals using a phosphor
imager was performed as described (Hartl and Bister,1998; Hartl et al.,
2001, 2006), and all results were conﬁrmed in several independent
experiments.
Protein–DNA interaction analyses
The preparation of solubilized and renatured proteins fromwashed
inclusion bodies containing v-Myc recombinant protein Myc p16
(Kerkhoff et al., 1991) or chicken Jun recombinant proteins CV (Hartl et
al., 2001) and CJ (Hartl and Bister, 1998), the preparation of nuclear
extracts from subconﬂuently grown cells, the generation of 32P-
labeled double-stranded oligodeoxynucleotides, and electrophoretic
mobility shift assays (EMSA) were carried out as described (Hartl and
Bister, 1998; Hartl et al., 2001, 2006). Dissociation constants of Jun–
DNA complexes were determined by competition of binding reactions
with increasing amounts of unlabeled AP-1 BS oligodeoxynucleotides.
For estimation of the dissociation constant (KD), radioactive areas of
the dried gel were quantiﬁed by phosphorimaging. Ratios of bound
and free DNA concentrations were determined, and free protein
concentrations were calculated from the equilibria equations of
normal and competed binding reactions. KD was then determined
according to KD=[DNA] [protein] / [DNA–protein] (Papoulas et al.,
1992; Hartl and Bister, 1998).
Chromatin-immunoprecipitation (ChIP) analyses were carried out
using sheared extracts derived from formaldehyde-treated ASV17-
transformed QEF or CEF, or normal QEF or CEF as described (Hartl et
al., 2006; Reiter et al., 2007). Immunoprecipitations were performed
with Jun-, Fos- or Gag-speciﬁc antibodies followed by PCR ampliﬁca-
tion of a 381-bp or a 177-bp fragment from the quail or chicken TOJ3
promoter regions, respectively, using the quail TOJ3-speciﬁc primer
pair 5′-TCGTCCCTAAAGTGCTGC-3′ and 5′-TATTGGGAAGAGCGGCAC-3′
encompassing nucleotides −405 to −25, or with the chicken TOJ3-
speciﬁc primer pair 5′-CCTACGGTGCTGCCGTAT-3′ and 5′-AAGAAAC-
GAGGCTGGCAC-3′ encompassing nucleotide positions 1323 to 1500 of
sequence contig NW_001471752.
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